Angiotensin II activates plasminogen activator inhibitor-I promoter in renal tubular epithelial cells via the AT1 receptor

Acta Physiologica Hungarica

Volumn 94, Issue 1-2, 2007, Pages 19-30

  Fintha, A ^a   Sebe, A ^a   Masszi, A ^a   Terebessy, T ^a   Huszar T ^a   Rosivall, L ^a   Mucsi, Istvan ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Angiotensin II; Mitogen activated protein kinases; Plasminogen activator inhibitor 1; Renal tubular cell; Transcriptional regulation; Tyrosine kinases

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN II, DES ASP(1) DES ARG(2) ILE(5); ANGIOTENSIN II, DES-ASP(1)-DES-ARG(2)-ILE(5)-; DRUG DERIVATIVE; GENISTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN TYROSINE KINASE; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; EPITHELIUM CELL; GENETIC TRANSFECTION; KIDNEY PROXIMAL TUBULE; PHYSIOLOGY; PROMOTER REGION; RABBIT; SWINE;

ANGIOTENSIN II; ANIMALS; CELLS, CULTURED; EPITHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENISTEIN; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KIDNEY TUBULES, PROXIMAL; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROMOTER REGIONS (GENETICS); PROTEIN-TYROSINE KINASES; RABBITS; RECEPTOR, ANGIOTENSIN, TYPE 1; SUS SCROFA; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 34248229142     PISSN: 0231424X     EISSN: 15882683     Source Type: Journal    
DOI: 10.1556/APhysiol.94.2007.1-2.4     Document Type: Article

References (36)

1. Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Suzuki Y, Mezzano S, Plaza JJ, Egido J: Role of the renin-angiotensin system in vascular diseases: expanding the field. Hypertension 38, 1382-1387 (2001)
2. Border WA, Noble N: Maximizing hemodynamic-independent effects of angiotensin II antagonists in fibrotic diseases. Semin. Nephrol. 21, 563-572 (2001)
3. Ma L, Fogo AB: Role of angiotensin II in glomerular injury. Semin. Nephrol. 21, 544-553 (2001)
4. Cao Z, Cooper ME: Role of angiotensin II in tubulointerstitial injury. Semin. Nephrol. 21, 554-562 (2001)
5. Ruiz-Ortega M, Ruperez M, Esteban V, Rodriguez-Vita J, Sanchez-Lopez E, Carvajal G, Egido J: Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases. Nephrol. Dial. Transplant. 21, 16-20 (2006)
6. Hunyady L, Catt KJ: Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Mol. Endocrinol. 20, 953-970 (2006)
7. Yu L, Border WA, Anderson I, McCourt M, Huang Y, Noble NA: Combining TGF-beta inhibition and angiotensin II blockade results in enhanced antifibrotic effect. Kidney Int. 66, 1774-1784 (2004)
8. Wang L, Eberhard M, Erne P: Stimulation of DNA and RNA synthesis in cultured rabbit cardiac fibroblasts by angiotensin IV. Clin. Sci. (Lond) 88, 557-562 (1995)
9. Kerins DM, Hao Q, Vaughan DE: Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV. J. Clin. Invest. 96, 2515-2520 (1995)
10. Li Q, Zhang L, Pfaffendorf M, van Zwieten PA: Comparative effects of angiotensin II and its degradation products angiotensin III and angiotensin IV in rat aorta. Br. J. Pharmacol. 116, 2963-2970 (1995)
11. Esteban V, Ruperez M, Sanchez-Lopez E, Rodriguez-Vita J, Lorenzo O, Demaegdt H, Vanderheyden P, Egido J, Ruiz-Ortega M: Angiotensin IV activates the nuclear transcription factor-kappaB and related proinflammatory genes in vascular smooth muscle cells. Circ. Res. 96, 965-973 (2005)
12. Albiston AL, McDowall SG, Matsacos D, Sim P, Clune E, Mustafa T, Lee J, Mendelsohn FA, Simpson RJ, Connolly M, Chai SY: Evidence that the angiotensin IV (AT(4)) receptor is the enzyme insulin-regulated aminopeptidase. J. Biol. Chem. 276, 48623-48626 (2001)
13. Eddy AA: Progression in chronic kidney disease. Adv. Chronic. Kidney Dis. 12, 353-365 (2005)
14. Ridker PM, Gaboury CL, Conlin PR, Seely EW, Williams GH, Vaughan DE: Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function. Circulation 87, 1969-1973 (1993)
15. van Leeuwen RT, Kol A, Andreotti F, Kluft C, Maseri A, Sperti G: Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells. Circulation 90, 362-368 (1994)
16. Wilson HM, Haites NE, Booth NA: Effect of angiotensin II on plasminogen activator inhibitor-1 production by cultured human mesangial cells. Nephron 77, 197-204 (1997)
17. Motojima M, Ando T, Yoshioka T: Sp1-like activity mediates angiotensin-II-induced plasminogen-activator inhibitor type-1 (PAI-1) gene expression in mesangial cells. Biochem. J. 349, 435-441 (2000)
18. Gesualdo L, Ranieri E, Monno R, Rossiello M, Colucci RM, Semeraro N, Grandaliano G, Schena FP, Ursi M, Cerullo G: Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells. Kidney Int. 56, 461-470 (1999)
19. Rodriguez-Iturbe B, Johnson RJ, Herrera-Acosta J: Tubulointerstitial damage and progression of renal failure. Kidney Int. Suppl, S82-86 (2005)
20. Mucsi I, Skorecki KL, Goldberg HJ: Extracellular signal-regulated kinase and the small GTP-binding protein, Rac, contribute to the effects of transforming growth factor-beta1 on gene expression. J. Biol. Chem. 271, 16567-16572 (1996)
21. Andreka P, Zang J, Dougherty C, Slepak TI, Webster KA, Bishopric NH: Cytoprotection by Jun kinase during nitric oxide-induced cardiac myocyte apoptosis. Circ. Res. 88, 305-312 (2001)
22. Schiffer M, Schiffer LE, Gupta A, Shaw AS, Roberts IS, Mundel P, Bottinger EP: Inhibitory smads and tgf-Beta signaling in glomerular cells. J. Am. Soc. Nephrol. 13, 2657-2666 (2002)
23. Huszar T, Mucsi I, Antus B, Terebessy T, Jeney C, Masszi A, Hunyady L, Mihalik B, Goldberg HJ, Thekkumkara TJ, Rosivall L: Extracellular signal-regulated kinase and the small GTP-binding protein p21Rac1 are involved in the regulation of gene transcription by angiotensin II. Exp. Nephrol. 9, 142-149 (2001)
24. Schmitz U, Thommes K, Beier I, Wagner W, Sachinidis A, Dusing R, Vetter H: Angiotensin II-induced stimulation of p21-activated kinase and c-Jun NH2-terminal kinase is mediated by Rac1 and Nck. J. Biol. Chem. 276, 22003-22010 (2001)
25. Terebessy T, Masszi A, Fintha A, Sebe A, Huszar T, Rosivall L, Mucsi I: Angiotensin II activates the human renin promoter in an in vitro model: the role of c-Jun-N-terminal kinase. Nephrol. Dial. Transplant. 19, 2184-2191 (2004)
26. Song JH, Cha SH, Hong SB, Kim DH: Dual blockade of the renin-angiotensin system with angiotensinconverting enzyme inhibitors and angiotensin II receptor blockers in chronic kidney disease. J. Hypertens. Suppl. 24S, 101-106 (2006)
27. Liu Y: Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int. 69, 213-217 (2006)
28. Bitzer M, Sterzel RB, Bottinger EP: Transforming growth factor-beta in renal disease. Kidney Blood Press. Res. 211-212 (1998)
29. Gaedeke J, Peters H, Noble NA, Border WA: Angiotensin II, TGF-beta and renal fibrosis. Contrib. Nephrol. 153-160 (2001)
30. Vaughan DE: PAI-1 and TGF-beta: unmasking the real driver of TGF-beta-induced vascular pathology. Arterioscler. Thromb. Vasc. Biol. 26, 679-680 (2006)
31. Haendeler J, Ishida M, Hunyady L, Berk BC: The third cytoplasmic loop of the angiotensin II type 1 receptor exerts differential effects on extracellular signal-regulated kinase (ERK1/ERK2) and apoptosis via Ras- and Rap1-dependent pathways. Circ. Res. 86, 729-736 (2000)
32. Eguchi S, Dempsey PJ, Frank GD, Motley ED, Inagami T: Activation of MAPKs by angiotensin II in vascular smooth muscle cells. Metalloprotease-dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK. J. Biol. Chem. 276, 7957-7962 (2001).
33. Murasawa S, Matsubara H, Mori Y, Masaki H, Tsutsumi Y, Shibasaki Y, Kitabayashi I, Tanaka Y, Fujiyama S, Koyama Y, Fujiyama A, Iba S, Iwasaka T: Angiotensin II initiates tyrosine kinase Pyk2-dependent signalings leading to activation of Rac1-mediated c-Jun NH2-terminal kinase. J. Biol. Chem. 275, 26856-26863 (2000)
34. Heeneman S, Haendeler J, Saito Y, Ishida M, Berk BC: Angiotensin II induces transactivation of two different populations of the platelet-derived growth factor beta receptor. Key role for the p66 adaptor protein Shc. J. Biol. Chem. 275, 15926-15932 (2000)
35. Weng YI, Shukla SD: Angiotensin II activation of focal adhesion kinase and pp60c-Src in relation to mitogen-activated protein kinases in hepatocytes. Biochim. Biophys. Acta 1589, 285-297 (2002)
36. Berk BC: Angiotensin II signal transduction in vascular smooth muscle: pathways activated by specific tyrosine kinases. J. Am. Soc. Nephrol. 10 (Suppl 11), S62-68 (1999)